Acute effects of GIP and GLP ‐1 receptor antagonism in totally pancreatectomized individuals: A randomized double‐blind, placebo‐controlled crossover study

Documenti analoghi

• Acute GIP and GLP ‐1 Administration Exerts Differential Metabolic Effects in Totally Pancreatectomised Individuals
  di: Liva S. L. Krogh, et al.
  Pubblicazione: (2026)
• GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide
  di: Katrine D. Galsgaard, et al.
  Pubblicazione: (2025)
• Glucose‐dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes—A randomised placebo‐controlled study
  di: Bjørn Hoe, et al.
  Pubblicazione: (2025)
• Oxytocin mRNA is expressed throughout the small intestine in individuals with and without type 2 diabetes, and circulating neurophysin I declines after Roux‐en‐Y gastric bypass surgery
  di: Ida M. Gether, et al.
  Pubblicazione: (2025)
• Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge
  di: Lærke Smidt Gasbjerg, et al.
  Pubblicazione: (2024)